vanoxerine has been researched along with yohimbine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Kile, BM; Park, J; Wightman, RM | 1 |
| Chen, GJ; Cheng, J; Duffney, LJ; Liu, A; Liu, S; Wei, J; Xiong, Z; Yan, Z | 1 |
4 other study(ies) available for vanoxerine and yohimbine
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Anesthetics, Local; Animals; Anterior Thalamic Nuclei; Chromatography, High Pressure Liquid; Desipramine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Electric Stimulation; Electrochemical Techniques; Lidocaine; Male; Microelectrodes; Neural Pathways; Norepinephrine; Piperazines; Raclopride; Rats; Rats, Sprague-Dawley; Septal Nuclei; Tissue Distribution; Yohimbine | 2009 |
Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Attention; Benzazepines; Biophysics; Central Nervous System Stimulants; Discrimination, Psychological; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Postsynaptic Potentials; Gene Expression Regulation; In Vitro Techniques; Male; Maprotiline; Methylphenidate; Motor Activity; Neurons; Peptides; Piperazines; Prefrontal Cortex; Rats; Receptors, Glutamate; Recognition, Psychology; RNA, Messenger; Synaptosomal-Associated Protein 25; Yohimbine | 2014 |